Ihc – Cd 10

2,000.00

Categories: ,

The CD10 test is an Immunohistochemistry (IHC) test that detects the CD10 protein on the surface of certain cells using a tissue sample. CD10 is a cell surface enzyme also known as neprilysin. It is expressed in a variety of normal and abnormal tissues, including:

• Early lymphoid progenitor cells
• Certain types of leukemia and lymphomas (e.g., follicular lymphoma, Burkitt lymphoma)
• Some carcinomas (e.g., renal cell carcinoma, endometrial stromal sarcoma)
• Stromal cells in breast and other cancers

CD10 staining helps pathologists identify the origin of undifferentiated or poorly differentiated tumors.

Enquiry Here

    Description

    Why It’s Done:

    The CD10 IHC test is used to:
    • Diagnose and classify hematologic malignancies, especially lymphomas and leukemias.
    • Differentiate between tumor types, especially when the origin of cancer is uncertain.
    • Identify certain types of solid tumors, such as renal cell carcinoma.
    • Assist in prognosis and treatment planning, especially when combined with other IHC markers.
    This test is often used alongside a panel of other markers to provide a clearer picture of the tumor’s nature.

    Preparation:

    • No special preparation is required from the patient.
    • The test is done on a formalin-fixed, paraffin-embedded tissue sample obtained during a biopsy or surgery.
    • Patients undergoing biopsy may need to follow specific instructions based on the procedure (e.g., fasting, stopping certain medications), as advised by the doctor.